HSV 1 & 2 direct kits & HSV 1 & 2 positive control pack kits

Active Purchase Order Awarded Last action

Contract number
W81K0022P0269
Awardee
Awarding agency
Obligated
$109,560

Award facts

Contract value 78% obligated
$139,650.00 Current and potential, with all options
Completion date 81% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00009 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-22-p-0269 with diasorin molecular, LLC. Is hereby… $0
Funding Only Action P00008 · In accordance with federal acquisition regulation (far) 52.232-18, availability of funds, FY26 funds are available and hereby obligated for delivery order… $27,930
Funding Only Action P00007 · The purpose for this modification is to DE-obligate excess FY23 funds, in order to reflect actual amounts used during performance of the contract in FY23 (01… -$2,160
Exercise an Option P00006 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-22-p-0269 with diasorin molecular, LLC. Is hereby… $0
Funding Only Action P00005 · HSV 1 & 2 direct kit - FY25 funding modification $27,930
Exercise an Option P00004 · HSV 1 & 2 direct kit - exercise the FY25 option year $0
Funding Only Action P00003 · HSV 1 & 2 direct kit - funding modification $27,930
Exercise an Option P00002 · Option year 1: HSV 1 & 2 direct kit $0
Funding Only Action P00001 · HSV 1 & 2 direct kit - FY23 funding modification $27,930
Original award $0

About this award

Written by GovTribe AI ·

The Defense Health Agency issued a purchase order to Diasorin Molecular, LLC for HSV 1 & 2 direct kits and positive control pack kits, with a ceiling value of $139,650.00, extending the existing contract W81K00-22-P-0269 for the period October 1, 2026 through September 30, 2027 (Option Period 4). Place of performance is Fort Sam Houston, Texas. The order carries firm fixed-price pricing with no small business set-aside. This extension was issued pursuant to FAR 52.217-9 option language and reflects continuation of molecular diagnostic supply operations supporting Defense Health Agency medical operations.

Quick answers

Who was awarded contract W81K0022P0269?

W81K0022P0269 was awarded to Diasorin Molecular, LLC by Medical Command (Department of the Army) on October 1, 2022.

How much is contract W81K0022P0269 worth?

The government has obligated $109,560 on W81K0022P0269. Its current value, with exercised options, is $139,650.

Which agency awarded contract W81K0022P0269?

Medical Command (Department of the Army) awarded W81K0022P0269, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0022P0269 competed?

The extent of competition for W81K0022P0269 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login